Centers for Disease Control - CGH

Description

The Award Ceiling for Year 1 is 0 (none). CDC anticipates an Approximate Total Fiscal Year Funding amount of $5,000,000 for Year 1, subject to the availability of funds.This NOFO will support Ministries of Health and other stakeholders in Central America to introduce and/or scale up high-impact, WHO-recommended site-level HIV interventions. Key HIV prevention and diagnosis activities include index testing, differentiated service modalities at key population testing facilities, self-testing, pre-exposure prophylaxis (PreP), rapid recency testing and response to clusters of recent transmission, and linkage to treatment for newly diagnosed individuals. Key HIV treatment activities include linkage to care registries, early treatment initiation, differentiated service delivery models, opportunistic infection diagnosis and treatment, lost-to follow-up reengagement, quality assurance in viral load networks, and drug resistance monitoring. Expected outcomes related to the First 95 (Reach-Diagnose-Link) of the UNAIDS 95-95-95 goals include increased access to HIV testing and yield among key populations and index case partners, improved public health response to active transmission clusters, and consistently high (>95%) linkage to treatment. Expected outcomes for the Second and Third 95 (Treat-Retain-Virally Suppress) include increased early treatment initiation, retention and adherence, improved access to viral load testing and HIV drug resistance monitoring, and sustained viral suppression. The NOFO also includes above-site technical assistance to advance the integration of PEPFAR-supported strategies into national guidelines, manuals, and systems.

Who can apply

• Unrestricted

Contact

Randolph Williams
gur2@cdc.gov